Mastopexy

Global Mastopexy Market to Reach US$2.3 Billion by 2030

The global market for Mastopexy estimated at US$1.7 Billion in the year 2024, is expected to reach US$2.3 Billion by 2030, growing at a CAGR of 5.7% over the analysis period 2024-2030. Crescent Breast Lift Technique, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$1.2 Billion by the end of the analysis period. Growth in the Benelli Lift Technique segment is estimated at 4.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$435.7 Million While China is Forecast to Grow at 5.4% CAGR

The Mastopexy market in the U.S. is estimated at US$435.7 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$368.4 Million by the year 2030 trailing a CAGR of 5.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.2% and 4.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.

Global Mastopexy Market – Key Trends & Drivers Summarized

Why Is Mastopexy Gaining Popularity Beyond Cosmetic Appeal?

Mastopexy, commonly known as breast lift surgery, has evolved significantly from being a purely aesthetic procedure to one increasingly recognized for its functional and psychological benefits. Originally sought by women aiming to restore youthful breast contours after pregnancy or weight loss, mastopexy is now widely performed to address issues such as breast asymmetry, skin laxity, and discomfort caused by sagging. The rising acceptance of body positivity and a growing emphasis on individualized aesthetic goals have led to a cultural shift—where women of varying ages and backgrounds are opting for the procedure not out of vanity, but as a means to restore bodily harmony and self-confidence. Moreover, the post-mastectomy and gender affirmation surgery markets are increasingly incorporating mastopexy as a complementary reconstructive solution. The reduced social stigma around plastic surgery and a growing awareness of advanced, less invasive techniques have also broadened the candidate pool for mastopexy procedures. Today’s patients are more informed, with access to detailed procedural information, peer reviews, and before-after visuals, making them confident and proactive in their decision-making. The intersection of health, aesthetics, and emotional well-being is pushing mastopexy into mainstream surgical conversations, supported by a rise in consultations from women seeking both restorative and enhancement outcomes.

How Are Technological Innovations Transforming Surgical Precision and Patient Outcomes?

Rapid advancements in surgical technology and technique are reshaping the mastopexy landscape, offering both surgeons and patients more predictable outcomes, shorter recovery times, and minimized scarring. Modern mastopexy techniques—such as vertical (lollipop) lifts, periareolar lifts, and the combined augmentation-mastopexy—allow surgeons to tailor interventions to each patient’s anatomical needs and aesthetic preferences. High-resolution 3D imaging systems are enabling detailed pre-surgical simulations, helping patients visualize potential results and make more informed choices. Surgical tools like electrocautery devices and refined suturing materials are contributing to cleaner incisions and reduced healing complications. Moreover, the integration of tissue tightening technologies, such as radiofrequency-assisted mastopexy, is enabling less invasive procedures with quicker recovery. Anesthesia protocols have also improved, making outpatient mastopexy more accessible and reducing post-operative discomfort. These innovations are not only improving cosmetic results but are also expanding the appeal of the procedure to older demographics and those previously hesitant due to concerns about downtime or surgical risk. Enhanced recovery pathways and the ability to combine mastopexy with fat grafting or implant-based augmentation are giving patients greater flexibility in customizing their outcomes. As techniques become more refined, mastopexy is transitioning from a complex reconstructive task to a precision-based, highly predictable cosmetic solution.

Is the Surge in Elective Surgeries and Consumer Empowerment Reshaping Demand?

The global rise in elective cosmetic procedures is directly influencing the demand trajectory for mastopexy, driven by shifting consumer attitudes, increasing disposable income, and improved access to specialized care. A growing segment of patients now view plastic surgery as part of a broader lifestyle choice, intertwined with self-care, wellness, and long-term body image satisfaction. Social media has played a catalytic role in normalizing discussions around cosmetic surgery, with influencers, celebrities, and everyday individuals sharing their journeys openly and demystifying the process. This transparency has significantly reduced hesitation and encouraged younger patients to explore surgical solutions earlier in life, often seeking mastopexy as a preventive measure post-pregnancy or during major weight transformations. Furthermore, international travel for medical procedures—commonly referred to as cosmetic tourism—has expanded access to skilled surgeons in cost-effective markets, increasing overall procedural volume. Meanwhile, clinics are refining the patient experience with concierge-style services, digital consultation platforms, and flexible financing options, making mastopexy more approachable. The demographic diversification of the patient base is particularly notable, with rising interest from non-traditional regions and cultural groups that previously underutilized plastic surgery services. This evolving landscape reflects a broader societal shift where personal autonomy and confidence are central to health and wellness, driving greater receptivity toward aesthetic enhancements like mastopexy.

What Are the Core Drivers Powering the Mastopexy Market’s Expansion?

The growth in the mastopexy market is driven by several factors rooted in clinical innovation, consumer behavior, and demographic shifts. The proliferation of advanced surgical techniques that minimize scarring and improve recovery times has lowered entry barriers and expanded the eligible patient population. Increasing demand from postpartum women seeking post-pregnancy body contouring solutions is a significant driver, particularly as part of broader “mommy makeover” packages. Similarly, the rising popularity of massive weight loss—often following bariatric surgery or fitness-focused lifestyle changes—is generating a new wave of patients seeking corrective procedures for excess skin and tissue laxity. Enhanced patient education, fueled by online platforms, virtual consultations, and peer-generated content, is encouraging more women to pursue mastopexy with informed confidence. The growing availability of certified plastic surgeons in emerging markets is also democratizing access, leading to a geographic broadening of the market. Additionally, demand is being boosted by the trend of combining mastopexy with other procedures, such as breast augmentation or fat transfer, enabling patients to achieve multiple aesthetic goals with a single surgery. Insurance coverage in reconstructive contexts—such as post-cancer or post-trauma cases—is adding a clinical dimension to what was once a purely cosmetic category. Lastly, the increasing personalization of surgical outcomes, facilitated by imaging, data, and consultation tools, is aligning mastopexy procedures more closely with individual identity and lifestyle aspirations, sustaining long-term growth.

SCOPE OF STUDY:

The report analyzes the Mastopexy market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Technique (Crescent Breast Lift Technique, Benelli Lift Technique, Benelli-Lollipop Lift Technique, Full Mastopexy Technique); End-Use (Hospitals End-Use, Specialty Clinics End-Use)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 48 Featured) -

• AbbVie
• Allergan
• Bausch Health
• CollPlant
• Cynosure Inc.
• Establishment Labs
• Galderma
• GC Aesthetics
• Groupe Sebin SAS
• Guangzhou Wanhe Plastic Materials
• Hologic
• Integra LifeSciences
• Lipoelastic
• Lumenis
• Mentor Worldwide LLC
• Merz Aesthetics
• POLYTECH Health & Aesthetics
• RTI Surgical
• Sientra Inc.
• SOLTA Medical

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.